Company news
Prenetics Global Limited (NASDAQ:PRE) news
Every Prenetics Global Limited press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
August 26, 2026
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Mo...
August 18, 2026
Prenetics Global : 2Q26 Letter to Shareholders
August 18, 2026
Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Confer...
August 7, 2026
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized...
June 10, 2026
Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates T...
June 4, 2026
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
May 20, 2026
Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue ...
May 14, 2026
Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
May 8, 2026
Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
May 7, 2026
Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Ye...
April 14, 2026
Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
April 2, 2026
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
March 24, 2026
Prenetics to Participate in the 38th Annual ROTH Conference
March 18, 2026
Prenetics Authorizes $40 Million Share Repurchase Program
March 6, 2026
Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal I...
March 3, 2026
Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours
February 23, 2026
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
February 18, 2026
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
February 18, 2026
Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
February 17, 2026
Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
February 13, 2026
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
February 11, 2026
Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation
January 5, 2026
Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
December 30, 2025
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure
December 23, 2025
Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million
November 24, 2025
Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Ind...
November 10, 2025
Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call
November 4, 2025
Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
October 28, 2025
Prenetics Announces $48.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
October 27, 2025
Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM...
October 27, 2025
Prenetics Global Limited Announces Proposed Public Offering
October 24, 2025
Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore
September 30, 2025
Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End
September 12, 2025
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
June 18, 2025
Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon
June 12, 2025
IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event
April 9, 2025
Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market
March 18, 2025
Prenetics to Participate in the 37th Annual ROTH Conference
March 11, 2025
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
March 5, 2025
Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve
February 11, 2025
Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham
January 21, 2025
Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials
January 15, 2025
Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements
December 19, 2024
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with Sp...
December 5, 2024
Prenetics Announces Participation in December Investor Conferences
December 4, 2024
Prenetics Announces Third Quarter 2024 Financial Results
November 27, 2024
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
November 18, 2024
Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
October 30, 2024
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
October 15, 2024